1. Okada J, Yoshikawa K, Imazeki K, Minoshima S, Uno K, Itami J, et al. The use of FDG-PET in the detection and management of malignant lymphoma: Correlation of uptake with prognosis.J Nucl Med 32: 686–691, 1991.
2. Okada J, Yoshikawa K, Itami M, Imaseki K, Uno K, Itami J, et al. Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: A comparison with proliferative activity.J Nucl Med 33: 325–329, 1992.
3. Schrape S, Jones DB, Wright DH. A comparison of three methods for the determination of the growth fraction in non-Hodgkin’s lymphoma.Br J Cancer 55: 283–286, 1987.
4. Hall PA, Richards MA, Gregory WM, d’Ardenne AJ, Lister TA, Stansfeld A. The prognostic value of Ki-67 immunostaining in non-Hodgkin’s lymphoma.J Pathol 1554: 223–235, 1988.
5. Kern KA, Brunetti A, Norton JA, et al. Metabolic imaging of human extremity musculoskeletal tumors by PET.J Nucl Med 29: 181–186, 1988.